1. Home
  2. SFBS vs ADMA Comparison

SFBS vs ADMA Comparison

Compare SFBS & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ServisFirst Bancshares Inc.

SFBS

ServisFirst Bancshares Inc.

HOLD

Current Price

$73.55

Market Cap

3.9B

Sector

Finance

ML Signal

HOLD

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

HOLD

Current Price

$9.15

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SFBS
ADMA
Founded
2005
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.6B
IPO Year
2014
2012

Fundamental Metrics

Financial Performance
Metric
SFBS
ADMA
Price
$73.55
$9.15
Analyst Decision
Buy
Buy
Analyst Count
3
2
Target Price
$87.50
$32.00
AVG Volume (30 Days)
333.2K
8.4M
Earning Date
04-20-2026
05-06-2026
Dividend Yield
2.09%
N/A
EPS Growth
21.63
N/A
EPS
5.06
0.60
Revenue
N/A
$42,219,783.00
Revenue This Year
$32.30
$27.46
Revenue Next Year
$10.30
$22.11
P/E Ratio
$14.38
$15.00
Revenue Growth
N/A
43.85
52 Week Low
$66.48
$7.21
52 Week High
$90.64
$25.67

Technical Indicators

Market Signals
Indicator
SFBS
ADMA
Relative Strength Index (RSI) 40.47 24.21
Support Level $71.24 N/A
Resistance Level $76.42 $16.44
Average True Range (ATR) 1.92 1.12
MACD 0.23 -0.53
Stochastic Oscillator 51.93 20.60

Price Performance

Historical Comparison
SFBS
ADMA

About SFBS ServisFirst Bancshares Inc.

Servisfirst Bancshares Inc is a bank holding company whose business is conducted by its wholly owned subsidiary. Through the subsidiary, it offers various banking services to individual and corporate customers in Birmingham, Florida, Georgia, North Carolina, South Carolina, Tennessee, and Virginia. Its various products and service offerings include commercial, consumer, and other loans; accepting deposits; providing electronic banking services, such as online and mobile banking, including remote deposit capture; delivering treasury and cash management services; and providing banking services to other financial institutions. The company operates as a single reportable segment, with a majority of its revenue being derived from the business of banking.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.

Share on Social Networks: